Rats were treated with N-nitrosomorpholin and subsequently with phenobarbital. After several weeks of phenobarbital treatment, foci of altered cells and tumors developed in the livers of the animals. In liver tumors, the activity of glutathione S-transferase was higher than in the surrounding tissue and remained elevated even after the withdrawal of the promoter. like the glutathioone S-transferase from normal liver, tumor glutathione S-transferase activity is composed of several, predominantly basic, isoenzymes with an apparent molecular weight of approximately 45,000.
INTRODUCTION
Glutathione S-transferases (GST) are ubiquitous enzymes which catalyze the conjugation of glutathione with hydrophobic substrates bearing an electrophilic center. Some GST isoenzymes can also bind hydrophobic ligands without catalyzing their biotransformation (6, 7) . Various GST were found in different types of cells (for review, see Ref. 5 ), but only a few and contradictory results have been reported on the presence of these enzymes in experimental liver tumors. In tumors which developed in rat liver after treatment with the cytotoxic agent 2-acetamidofluorene, GST activity has been found to be both lower (2) and higher (1) than in the surrounding tissue or in the liver of control animals. In the present study, we utilized an initiation/promotion model to produce liver tumors as we11 as their putative precursors. FoIIowing a single dose of the initiating carcinogen N-nitrosomorpholin (NNM) promotion was achieved with noncytotoxic agents like phenobarbital (PB) or n-hexachlo-Presented at the Second International Symposium sponsored by the Universities of Sassari and Cagliari. Session 11: "Characterization of hfetabolic and Biological Patterns," October 12-15, 1983. Alghero. Italy. This Symposium section cornplctcs the series of papers published in Volume 12. 1984. rocyclohexane. GST and microsomal monooxygenase (MO) were followed up with use of biochemic and immunohistochemic methods.
MATERIALS A N D M E T t i O D S
The experiments were done on female Wistar rats. The animals received a single oral dose of 250 mg of NNM/kg and after a few weeks of recovery, was added to PB the food as indicated in the legends to the table and figures. At the proper time, the animals were killed by decapitation, the livers were excised, and the tumors were separated. Tissue samples were homogenized with a 5-fold volume of cold 0.05 mol/Iiter of Tris-acetate buffer/liter, pH 7.5, in a Potter-Elvehjem homogenizer fitted with a Teflon pestle. Cytosol and microsomes were separated by differential centrifugation. For the determination of GST activity, the microsomes were washed twice with the homogenizing buffer. The methods for determination of GST activity (S), MO activity (111, and protein concentration (3) were as described.
Specific antisera against GST isoenzymes of rat liver cytosol were obtained through the courtesy of Drs. Zwisler and Ronneberger from Be h ringrvcrke, Marburg. Electrophore t -ically homogeneous GST isoenzymes used as antigens were separated on a CM-cellulose (6) and finally purified by affinity chromatography (8) and gel filtration.
GST-B was localized in acetone-fixed sections of liver tissue by immunohistochemic methods (9, 12) . y-GT (glutamyltranspeptidase) was demonstrated according to the method of Rutenberg et al. (10) .
Chromatofocusing of cytosolic GST was done on a Polybuffer Exchanger PBE 118 column (Pharmacia), 4 1 x 50 cm in dimension, equilibrated with 0.025 mol of triethanolamine buffer/liter, pH 10.5. Then 4 ml of cytosol were adjusted to pH 10 and loaded on the column. A gradient from pH 10 to 7 was generated by eluting the column with an ampholyte mixture containing 2.25 ml of Servalyt Buffer 04 and 2.75 ml of Servalyt 9-11 in 1 liter. The solution was adjusted to pH 7 with HCI. Servalyt Buffer 04 and Servalyt 9-11 are products of Serva, Heidelberg. Apparent iM, (molecular weight) was determined by gel filtration on a Sephadex G-75 column (4 1 X 60 cm) calibrated with bovine serum albumin, egg albumin, pepsin, soybean trypsin inhibitor, and lysozyme.
RESULTS

GST in Foci of Putative Preneoplastic
Cells. The animals were treated with NNM alone or with NNM and PB as described for Table I . After death, liver sections were made and stained for GST-B and y-GT as described under "Materials and Methods." The occurrence of both enzymes in foci of putative preneoplastic cells was compared in serial sections. The results are presented in Table  I . All foci contained GST-B but some foci contained y-GT as well. The coincidence of GST-B-and y-GT positivity depended on the pretreatment. In the livers of animals that received only NNM, about 40% of GST-Bpositive'foci were also y-GT-positive. On the other hand, the coincidence was higher than 80% in animals treated with both substances.
TABLE I-GST-B and a-GT in Foci in Putative Preneoplastic Cells
2. GST in Experimental Liver Tumors. In this series of experiments, the animals were treated either with NNM alone, PB alone,,or NNM and PB as indicated for Figure 1 . The animals that received both substances developed liver tumors. At the proper time, the rats were killed, the livers excised, and the activity of cytosolic and microsomal GST in the tumors and in the macroscopically unchanged tissue was determined as described under "Materials and Methods.'' The results are given in Figure 1 and 2. NNM alone and PB alone had little or no influence on the activity of both cytosolic and microsomal GST. On the other hand, treatment with both substances resulted in a significant, dose-dependent increase of GST activity in both cytosol and microsomes. In most cases, the mean GST activity in the tumors was significantly higher than in the surrounding tissue and 2-3 times higher than in the controls. These results were confirmed in subsequent experiments. As a rule, the activity of GST in the tumors was by 21-44s higher than in the surrounding tissue and in 3 out of 4 experiments, the difference was statistically significant ( p < 0.05). If the promoter was withdrawn 4-6 weeks prior to death, the activity of GST in macroscopically unchanged liver tissue decreased and reached the same level as in the untreated animals. At the same time, the GST activity in the tumors also decreased, but it still remained higher than in the surrounding tissue. These results are in contrast with those obtained with MO. The average activity of MO in the tumors was nearly as high as in the surrounding tissue if the promoter was given until death; but, after the withdrawal of the promoter, the activity of MO in the tumors dropped below the limit of detection (see Fig. 3 ). We also compared some properties of soluble GST from normal liver with those from experimental liver tumors. The double diffusion test which was done with antisera raised against the hepatic GST-A (immunochemically indistinguishable from GST-C, see Kef. 6). GST-B and -E showed identical results for cytosol from both normal liver and tumor tissue (Fig. 4) . The isoenzyme pattern of soluble GST in normal liver tissue and in experimental tumors was examined with use of chromatofocusing. The results of three specimen runs are presented in Figure 5 . It may be seen that in norma1 liver cytosol, there are six GST isoenzymes or isoenzyme groups at least which may be separated according to their isoelectric points. Similar GST isoenzyme patterns were obtained with tumor cytosol, but there were some differences in the relative abundance of some isoenzymes, especially in the tumor with a high specific GST activity. In each case, more than 85% of the GST activity which was loaded onto the column were recovered in the eluate, another 5-8% was washed down with 1 mol/liter of NaCI. The elution volume of tumor GST isoenzymes from the Sephadex G-75 column was the same as that of egg albumin indicating an apparent M, of approximately 45,000, i.e., the same as for GST from normal liver (6) .
DISCUSSION
Soluble GST of tumor and normal liver seem to be similar in several aspects. They have the same antigenic properties as demonstrated by Ouchterlony test, and, regardless of some quantitative differences, a similar elution pattern from a chromatofocusing column. In addition, GST from normal and neoplastic liver tissue has the same apparent M, as determined by gel filtration. Thus, our results did not provide evidence for some tumor-specific GST. However, the average specific activity of both cytosolic and micro-soma1 GST in liver tumors was higher than in the surrounding tissue and still higher than in the livers of control animals. In contrast to the microsomal MO, the activity of GST in the tumors remained elevated even after the withdrawal of the promoter.
GST was also contained in all foci of putative preneoplastic cells including the r-GTnegative ones. As may be judged from the intensity of the stain, the amount of GST-B immunoreactive protein in some foci appeared to be higher than in the surrounding tissue.
Therefore, the question arises whether the GST in liver foci contributes to the resistance of focal cells against various xenobiotic poisons. This resistance is believed to provide a 
